US Oncology Research
Through Texas Oncology, patients can take part in exciting new clinical trials and novel therapies - right in their own communities. Texas Oncology is a primary participant in US Oncology Research, a nationwide effort consisting of 170 research locations with an experienced staff of more than 300 dedicated research professionals.
Through this highly efficient organization, new drugs and therapies are sped from the research lab into the real world, reaching patients as quickly as possible. Eleven anticancer drugs have received FDA approval, largely due to the work of US Oncology Research.
As the largest practice that contributes to this vast research community, Texas Oncology has played a key role in the accrual of over 16,000 cancer patients participating in clinical trials. Over 90 trials are currently being conducted involving chemotherapy, immunotherapy, stem cell transplantation and gene therapy.
Access to this extensive network of research and clinical trials gives cancer patients across Texas the added advantage of cutting-edge expertise and treatments that may save their lives.